Navana Pharmaceuticals PLC (DSE:NAVANAPHAR)

Bangladesh flag Bangladesh · Delayed Price · Currency is BDT
49.30
-1.70 (-3.33%)
At close: Dec 4, 2025
-7.85%
Market Cap5.30B
Revenue (ttm)9.52B
Net Income (ttm)537.75M
Shares Out107.42M
EPS (ttm)4.99
PE Ratio9.89
Forward PEn/a
Dividend1.40 (2.84%)
Ex-Dividend DateNov 20, 2025
Volume279,736
Average Volume331,215
Open51.00
Previous Close51.00
Day's Range48.90 - 51.50
52-Week Range42.00 - 65.80
Beta-0.20
RSI41.97
Earnings DateJan 22, 2026

About Navana Pharmaceuticals

Navana Pharmaceuticals PLC engages in the manufacturing, marketing, and distribution of pharmaceutical and veterinary products in Bangladesh. It exports its products. Navana Pharmaceuticals PLC was incorporated in 1986 and is based in Dhaka, Bangladesh. [Read more]

Industry Pharmaceutical Preparations
Founded 1986
Employees 4,798
Stock Exchange Dhaka Stock Exchange
Ticker Symbol NAVANAPHAR
Full Company Profile

Financial Performance

In 2025, Navana Pharmaceuticals's revenue was 8.84 billion, an increase of 28.19% compared to the previous year's 6.90 billion. Earnings were 487.81 million, an increase of 20.56%.

Financial Statements

News

There is no news available yet.